MB, Levis & Associates’s Aflac AFL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$80.3K Buy
718
+3
+0.4% +$360 0.03% 93
2026
Q2
$83.8K Buy
715
+4
+0.6% +$460 0.03% 92
2026
Q1
$78K Buy
711
+4
+0.6% +$443 0.03% 91
2025
Q4
$78K Buy
707
+4
+0.6% +$441 0.03% 92
2025
Q3
$78.5K Buy
703
+4
+0.6% +$420 0.03% 91
2025
Q2
$73.8K Buy
699
+4
+0.6% +$420 0.03% 105
2025
Q1
$77.3K Buy
695
+3
+0.4% +$318 0.04% 100
2024
Q4
$71.6K Buy
692
+3
+0.4% +$327 0.04% 103
2024
Q3
$77K Buy
689
+3
+0.4% +$305 0.04% 100
2024
Q2
$61.2K Buy
686
+4
+0.6% +$344 0.03% 106
2024
Q1
$58.5K Buy
682
+5
+0.7% +$410 0.03% 112
2023
Q4
$55.9K Buy
677
+3
+0.4% +$242 0.03% 109
2023
Q3
$51.7K Buy
674
+4
+0.6% +$297 0.03% 112
2023
Q2
$46.8K Buy
670
+4
+0.6% +$268 0.03% 117
2023
Q1
$43K Buy
666
+4
+0.6% +$274 0.03% 117
2022
Q4
$47.6K Buy
+662
New +$44.3K 0.04% 108

Other funds holding AFL

MB, Levis & Associates's AFL Position: Q3 2026 in Review

MB, Levis & Associates increased its Aflac (AFL) stake by 0.42% in Q3 2026, buying an estimated $360 and bringing the position to 718 shares worth $80.3K. The position accounts for 0.03% of the portfolio, ranked #93.

MB, Levis & Associates first reported a position in AFL in Q4 2022 and has held it in 16 quarters since. The position peaked at $83.8K in Q2 2026. 970 funds tracked by Wall St. Rank hold AFL as of Q3 2026.

  • MB, Levis & Associates held 718 shares of Aflac worth $80.3K as of Q3 2026.
  • MB, Levis & Associates bought 3 Aflac shares in Q3 2026, an estimated $360.
  • Aflac made up 0.03% of MB, Levis & Associates's portfolio in Q3 2026, its #93 holding.
  • MB, Levis & Associates first reported a position in Aflac in Q4 2022 and has held it in 16 quarters since.
  • MB, Levis & Associates's Aflac position peaked at $83.8K in Q2 2026.
  • 970 funds tracked by Wall St. Rank held Aflac as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.